Global glycomics and glycobiology market to reach $4.66B by 2030 at 17% CAGR

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Glycomics or Glycobiology Market Projected To Reach By 2030?

The glycomics or glycobiology market has experienced rapid expansion in recent years. It is projected to grow from $2.13 billion in 2025 to $2.49 billion in 2026, achieving a compound annual growth rate (CAGR) of 17.1%. The historical growth can be attributed to advances in carbohydrate chemistry, the expansion of life sciences research, increased academic research funding, initial biomolecule characterization, and the development of analytical instruments.

The glycomics or glycobiology market is projected for significant expansion in the coming years. This market is predicted to reach $4.66 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.0%. Factors driving this growth during the forecast period include the widening scope of precision medicine, increased investments in pharmaceutical R&D, the growing need for biomarker discovery, advancements in mass spectrometry technology, and a rise in translational research. Key trends anticipated for the forecast period encompass the broadening of glycan-based biological research, an uptick in the application of glycomics for drug discovery, a heightened demand for sophisticated glycan analysis instruments, the increasing incorporation of glycobiology into diagnostics, and more frequent academic and industrial partnerships.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/glycomics-or-glycobiology-global-market-report

What Major Factors Are Driving The Glycomics or Glycobiology Market Forward?

The anticipated expansion of the glycomics or glycobiology market is largely driven by the rising need for pharmaceutical products. These products encompass medications or drugs meticulously developed to diagnose, prevent, manage, or resolve illnesses or health issues in both humans and animals. glycomics and glycobiology play a crucial role in pharmaceutical development by offering deep understanding of disease mechanisms, aiding in the identification of therapeutic targets, and enhancing the effectiveness and design of drugs for various medical conditions. As an illustration, in February 2024, the US-based non-profit organization, Personalized Medicine Coalition, reported that in 2023, the FDA sanctioned 16 novel personalized treatments for patients with rare diseases, an increase from six in 2022. Among the personalized treatments newly approved for 2023, there were also seven cancer drugs and three for different diseases and conditions. Consequently, the escalating demand for pharmaceutical products is fueling the expansion of the glycomics or glycobiology market.

How Are Segments Identified Within The Glycomics or Glycobiology Market Segment Framework?

The glycomics or glycobiology market covered in this report is segmented –

1) By Product: Enzymes, Kits, Reagents And Chemicals, Instruments, Carbohydrates

2) By Application: Drug Discovery And Development, Disease Diagnostics, Other Applications

3) By End-User: Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Clinical Laboratories

Subsegments:

1) By Enzymes: Glycosidases, Glycosyltransferases, Sialidases

2) By Kits: Glycan Analysis Kits, Glycobiology Research Kits

3) By Reagents And Chemicals: Monosaccharides, Oligosaccharides, Chemical Modifiers

4) By Instruments: Mass Spectrometers, Chromatography Systems, Imaging Systems

5) By Carbohydrates: Natural Carbohydrates, Synthetic Carbohydrates

Which Trends Are Impacting The Progress Of The Glycomics or Glycobiology Market?

Leading companies within the glycobiology market are concentrating on developing innovative solutions, such as glycan-display platforms, to accelerate the discovery of carbohydrate-based therapeutics and vaccines. Glycan-display platforms represent technologies that present diverse sugar molecules (glycans) on surfaces or scaffolds to study their interactions with proteins, cells, or pathogens, which is crucial for drug and vaccine development. For instance, in October 2024, CD BioGlyco, a US-based biotechnology company, launched its Glycan Display Platform. This is an advanced, integrated glycan-display technology offering multiple modalities, including traditional glycan arrays, cell-based glycan display, neoglycolipid (NGL) display, liquid glycan arrays (LiGA), glyco-phage display, and de novo glycan display, thereby supporting a wide array of glycobiology research applications, such as drug discovery and glycan-protein interaction studies. This platform utilizes synthesized or natural glycans and immobilizes or presents them on carriers like lipids, phage particles, or engineered cells, allowing researchers to explore glycan binding properties in various contexts (e.g., fluid versus immobilized, monovalent versus multivalent). Such functionalities enable high-throughput screening, precise control over glycan density or presentation format, and improved physiological relevance compared to traditional glycan microarrays, which commonly immobilize glycans on rigid surfaces.

Who Are The Companies Competing Within The Glycomics or Glycobiology Market?

Major companies operating in the glycomics or glycobiology market are Aligent Technologies Inc., Bruker Corporation, Merck Co. & KgaA, New England Biolabs Inc., Danaher Corporation, Shimadzu Corporation, ProZyme Inc., Takara Bio Inc., Asparia Glycomics SL, Lectenz Bio, Chemily Glycoscience LLC, Z Biotech LLC, RayBiotech Inc., Thermo Fisher Scientific Inc., Promega Corporation, Bio-Techne Corp., AMS Bio LLC, Ludger Ltd., CD BioGlyco Ltd., GlycoDiag SAS, Kode Biotech Limited, Glyxera GmBH, Glycomix Ltd., R&D Systems Inc.

Get The Full Glycomics or Glycobiology Market Report:

https://www.thebusinessresearchcompany.com/report/glycomics-or-glycobiology-global-market-report

Which Region Accounts For The Largest Portion Of The Glycomics or Glycobiology Market?

North America was the largest region in the glycomics or glycobiology market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the glycomics or glycobiology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Glycomics or Glycobiology Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/glycomics-or-glycobiology-global-market-report

Browse Through More Reports Similar to the Global Glycomics or Glycobiology Market 2026, By The Business Research Company

Glyphosate Market Report 2026

https://www.thebusinessresearchcompany.com/report/glyphosate-global-market-report

Glycomic Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/glycomic-therapeutics-global-market-report

Glycol Market Report 2026

https://www.thebusinessresearchcompany.com/report/glycol-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795